Literature DB >> 20688967

Pulmonary hypertension and NO in sickle cell.

Mark T Gladwin, Robyn J Barst, Oswaldo L Castro, Victor R Gordeuk, Cheryl A Hillery, Gregory J Kato, Daniel B Kim-Shapiro, Roberto Machado, Claudia R Morris, Martin H Steinberg, Elliott P Vichinsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20688967      PMCID： PMC2918336          DOI： 10.1182/blood-2010-04-282095

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  18 in total

1.  Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice.

Authors:  Dhananjay K Kaul; Xiao-du Liu; Hee-Yoon Chang; Ronald L Nagel; Mary E Fabry
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

2.  Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes.

Authors:  Laura M De Castro; Jude C Jonassaint; Felicia L Graham; Allison Ashley-Koch; Marilyn J Telen
Journal:  Am J Hematol       Date:  2008-01       Impact factor: 10.047

3.  Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin.

Authors:  Peter C Minneci; Katherine J Deans; Huang Zhi; Peter S T Yuen; Robert A Star; Steven M Banks; Alan N Schechter; Charles Natanson; Mark T Gladwin; Steven B Solomon
Journal:  J Clin Invest       Date:  2005-11-17       Impact factor: 14.808

4.  Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.

Authors:  Gregory J Kato; Vicki McGowan; Roberto F Machado; Jane A Little; James Taylor; Claudia R Morris; James S Nichols; Xunde Wang; Mirjana Poljakovic; Sidney M Morris; Mark T Gladwin
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

5.  Pulmonary hypertension in patients with sickle cell disease: a longitudinal study.

Authors:  Kenneth I Ataga; Charity G Moore; Susan Jones; Oludamilola Olajide; Dell Strayhorn; Alan Hinderliter; Eugene P Orringer
Journal:  Br J Haematol       Date:  2006-07       Impact factor: 6.998

6.  Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability.

Authors:  Lewis L Hsu; Hunter C Champion; Sally A Campbell-Lee; Trinity J Bivalacqua; Elizabeth A Manci; Bhalchandra A Diwan; Daniel M Schimel; Audrey E Cochard; Xunde Wang; Alan N Schechter; Constance T Noguchi; Mark T Gladwin
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

7.  Hemolysis-associated priapism in sickle cell disease.

Authors:  Vikki G Nolan; Diego F Wyszynski; Lindsay A Farrer; Martin H Steinberg
Journal:  Blood       Date:  2005-06-28       Impact factor: 22.113

8.  N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease.

Authors:  Roberto F Machado; Anastasia Anthi; Martin H Steinberg; Duane Bonds; Vandana Sachdev; Gregory J Kato; Angelo M Taveira-DaSilva; Samir K Ballas; William Blackwelder; Xiuli Xu; Lori Hunter; Bruce Barton; Myron Waclawiw; Oswaldo Castro; Mark T Gladwin
Journal:  JAMA       Date:  2006-07-19       Impact factor: 56.272

9.  A network model to predict the risk of death in sickle cell disease.

Authors:  Paola Sebastiani; Vikki G Nolan; Clinton T Baldwin; Maria M Abad-Grau; Ling Wang; Adeboye H Adewoye; Lillian C McMahon; Lindsay A Farrer; James G Taylor; Gregory J Kato; Mark T Gladwin; Martin H Steinberg
Journal:  Blood       Date:  2007-06-28       Impact factor: 22.113

10.  Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

Authors:  Mark T Gladwin; Vandana Sachdev; Maria L Jison; Yukitaka Shizukuda; Jonathan F Plehn; Karin Minter; Bernice Brown; Wynona A Coles; James S Nichols; Inez Ernst; Lori A Hunter; William C Blackwelder; Alan N Schechter; Griffin P Rodgers; Oswaldo Castro; Frederick P Ognibene
Journal:  N Engl J Med       Date:  2004-02-26       Impact factor: 91.245
View more
  32 in total

1.  Atorvastatin reduces serum cholesterol and triglycerides with limited improvement in vascular function in adults with sickle cell anemia.

Authors:  Candice Bereal-Williams; Roberto F Machado; Vicki McGowan; Amy Chi; Christian J Hunter; Gregory J Kato; Lori Hunter; Carole K Dalby; Kristine Partovi Hauser; Anitaben Tailor; Richard O Cannon
Journal:  Haematologica       Date:  2012-07-06       Impact factor: 9.941

2.  Vascular risk assessment in patients with sickle cell disease.

Authors:  Claudia R Morris
Journal:  Haematologica       Date:  2011-01       Impact factor: 9.941

3.  Inhaled nitrite reverses hemolysis-induced pulmonary vasoconstriction in newborn lambs without blood participation.

Authors:  Arlin B Blood; Hobe J Schroeder; Michael H Terry; Jeanette Merrill-Henry; Shannon L Bragg; Kurt Vrancken; Taiming Liu; Jason L Herring; Lawrence C Sowers; Sean M Wilson; Gordon G Power
Journal:  Circulation       Date:  2011-01-31       Impact factor: 29.690

4.  Storage lesion: role of red blood cell breakdown.

Authors:  Daniel B Kim-Shapiro; Janet Lee; Mark T Gladwin
Journal:  Transfusion       Date:  2011-04       Impact factor: 3.157

Review 5.  2015 Clinical trials update in sickle cell anemia.

Authors:  Natasha Archer; Frédéric Galacteros; Carlo Brugnara
Journal:  Am J Hematol       Date:  2015-10       Impact factor: 10.047

Review 6.  Cardiovascular abnormalities in sickle cell disease.

Authors:  Mark T Gladwin; Vandana Sachdev
Journal:  J Am Coll Cardiol       Date:  2012-03-27       Impact factor: 24.094

Review 7.  Pathophysiology and treatment of pulmonary hypertension in sickle cell disease.

Authors:  Victor R Gordeuk; Oswaldo L Castro; Roberto F Machado
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

8.  Angeli's salt counteracts the vasoactive effects of elevated plasma hemoglobin.

Authors:  Steven B Solomon; Landon Bellavia; Daniel Sweeney; Barbora Piknova; Andreas Perlegas; Christine C Helms; Gabriela A Ferreyra; S Bruce King; Nicolaas J H Raat; Steven J Kern; Junfeng Sun; Linda C McPhail; Alan N Schechter; Charles Natanson; Mark T Gladwin; Daniel B Kim-Shapiro
Journal:  Free Radic Biol Med       Date:  2012-10-23       Impact factor: 7.376

9.  Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension.

Authors:  Claudia R Morris; Hae-Young Kim; John Wood; John B Porter; Elizabeth S Klings; Felicia L Trachtenberg; Nancy Sweeters; Nancy F Olivieri; Janet L Kwiatkowski; Lisa Virzi; Sylvia T Singer; Ali Taher; Ellis J Neufeld; Alexis A Thompson; Vandana Sachdev; Sandra Larkin; Jung H Suh; Frans A Kuypers; Elliott P Vichinsky
Journal:  Haematologica       Date:  2013-04-12       Impact factor: 9.941

10.  Elevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomy.

Authors:  Sylvia T Singer; Frans Kuypers; Jeffery Fineman; Ginny Gildengorin; Sandra Larkin; Nancy Sweeters; Howard Rosenfeld; Gregory Kurio; Annie Higa; Michael Jeng; James Huang; Elliott P Vichinsky
Journal:  Ann Hematol       Date:  2014-02-28       Impact factor: 3.673
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.